Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
1.480
-0.020 (-1.33%)
Aug 11, 2025, 4:00 PM - Market closed
Paramount Global Employees
Compugen had 74 employees as of December 31, 2024. The number of employees increased by 6 or 8.82% compared to the previous year.
Employees
74
Change (1Y)
6
Growth (1Y)
8.82%
Revenue / Employee
$299,243
Profits / Employee
-$261,676
Market Cap
138.43M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 74 | 6 | 8.82% |
Dec 31, 2023 | 68 | -1 | -1.45% |
Dec 31, 2022 | 69 | -4 | -5.48% |
Dec 31, 2021 | 73 | 5 | 7.35% |
Dec 31, 2020 | 68 | 7 | 11.48% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CGEN News
- 3 days ago - Compugen: Potential Best-In-Class Anti-PVRIG COM701 Shifts To Targeting PSOC Patients - Seeking Alpha
- 4 days ago - Compugen Ltd. (CGEN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Compugen Reports Second Quarter 2025 Results - PRNewsWire
- 14 days ago - Compugen to Present a Pooled Analysis of COM701 Phase 1 trials in Platinum Resistant Ovarian Cancer at ESMO 2025 - PRNewsWire
- 19 days ago - Compugen to Release Second Quarter 2025 Results on Wednesday, August 6, 2025 - PRNewsWire
- 21 days ago - Compugen Announces First Patient Dosed in COM701 Global Platform Trial in Platinum Sensitive Ovarian Cancer - PRNewsWire
- 2 months ago - Compugen to Present AI/ML Driven Predictive Computational Research at Upcoming International Scientific Conferences - PRNewsWire
- 3 months ago - Compugen Ltd. (CGEN) Q1 2025 Earnings Call Transcript - Seeking Alpha